Research Peptides Australia: A Guide to Research Terminology and Documentation

Australia has a well-established and active research community spanning university laboratories, independent research organisations, and commercial research facilities. Researchers working with peptides — short chains of amino acids — rely on accurate terminology and thorough documentation to design experiments, interpret results, and maintain reproducible laboratory records.

This guide is an introductory reference for anyone navigating the terminology and documentation commonly encountered when sourcing, handling, and recording research peptides within an Australian laboratory context. It does not provide medical, therapeutic, or clinical advice, and it does not discuss human administration under any circumstances.

What Is a Peptide?

In a laboratory and biochemistry context, a peptide is a molecule consisting of two or more amino acids linked by peptide bonds. Amino acids are organic compounds that serve as the fundamental building blocks of proteins. When amino acids are joined in a specific sequence, the resulting molecule is described by its amino acid sequence and its molecular mass.

Peptides are generally distinguished from proteins by size, though there is no universally agreed boundary: some authorities describe peptides as chains of up to approximately 50 amino acids, with larger structures classified as proteins. In research supply catalogues, the term “peptide” typically refers to a synthetic or recombinantly produced amino acid chain supplied as a lyophilised (freeze-dried) powder for laboratory investigation.

A peptide’s identity is defined by its amino acid sequence. Its molecular mass — the combined mass of all atoms in the molecule, usually expressed in Daltons (Da) — can be calculated from that sequence and verified experimentally using techniques such as mass spectrometry.

For a closer look at how research peptides are supplied in multi-unit quantities, see our article on bulk peptides in Australia.

Product Identification in Research Catalogues

When reviewing a research peptide catalogue or product listing, several standard pieces of information help identify exactly what is being offered. Understanding these identifiers supports accurate record keeping and helps avoid confusion between products with similar or overlapping names.

Product Name and Sequence

The product name is typically the common or research name of the peptide (for example, a name ending in “-tide” or “-relin”). In many cases a product listing will also include the amino acid sequence — the specific order of amino acids that defines the molecule. The sequence is the most precise identifier; two products with different sequences are different molecules regardless of any similarity in their names.

Molecular Mass

The molecular mass (or molecular weight), usually reported in Daltons, provides a calculable reference point. If an analytical report lists a measured mass, researchers can compare the measured value against the theoretical mass calculated from the amino acid sequence. A close match supports identity confirmation; a significant discrepancy may indicate a different substance or an analytical issue.

Batch and Lot Numbers

A batch number (also called a lot number) is a unique alphanumeric identifier assigned by the manufacturer or supplier to a specific production run. Batch numbers are a critical component of traceable research documentation: they allow a researcher to link a specific vial to the analytical data produced for that production run, and they support consistent record keeping across experiments.

If an issue is identified with a particular batch, the batch number allows all recipients of material from that production run to be notified. In a well-documented research environment, every entry in a laboratory notebook that references a research product should record the batch number.

Analytical Documentation: Certificates and Reports

In research peptide supply, the most common form of analytical documentation is the Certificate of Analysis (COA). A COA is a document — typically issued by the testing laboratory or the supplier — that reports the results of one or more analytical tests performed on a specific batch. For an overview of how product specifications, batch information and analytical documentation are reviewed and presented, see our testing and quality process page.

HPLC: Purity Assessment

High-Performance Liquid Chromatography (HPLC) is a widely used analytical technique that separates components of a mixture. In peptide analysis, HPLC is typically used to estimate purity — the proportion of the sample that corresponds to the target peptide relative to other detectable components.

An HPLC report commonly includes a chromatogram (a graphical representation of detector response over time) and a calculated purity percentage. Important terminology includes:

• Retention time: the time it takes for a compound to travel through the chromatography column under specified conditions. A given compound has a characteristic retention time under consistent conditions.
• Peak area: the area under a peak in the chromatogram, used to estimate the relative amount of each component. Purity percentage is typically calculated as the main peak area divided by total peak area.
• Mobile phase and stationary phase: the two phases of the chromatographic system. The mobile phase (a liquid solvent mixture) carries the sample through the stationary phase (the column packing material), and compounds separate based on their differing interactions with each phase.

For a more detailed treatment, see the article on HPLC testing in this library.

Mass Spectrometry: Identity Confirmation

Mass spectrometry (MS) measures the mass-to-charge ratio of ionised molecules. In peptide analysis, MS is used to confirm the molecular mass of the sample — and therefore its identity. While HPLC answers the question “how pure is it?”, mass spectrometry answers the question “is this the right molecule?”.

A mass spectrum plots relative intensity against mass-to-charge ratio (m/z). For a pure peptide sample, the spectrum typically shows a prominent signal corresponding to the molecular ion, and the measured mass can be compared against the theoretical mass calculated from the amino acid sequence. See our article on mass spectrometry for a fuller explanation.

Lyophilised Products: Why Appearance Varies

Most research peptides are supplied as a lyophilised (freeze-dried) powder. Lyophilisation is a process that removes water from a frozen sample under vacuum, producing a dry, stable solid. The appearance of lyophilised material — sometimes a loose powder, sometimes a more compacted “puck” or film — can vary between batches and between different peptides, and this variation is normal.

Appearance alone does not indicate quality, purity, or identity. The analytical documentation (HPLC and MS data) is the appropriate reference for evaluating those characteristics. See the lyophilised products article for more detail.

Why Documentation Matters in a Research Context

Thorough documentation serves several purposes in laboratory research:

• Reproducibility: experiments should be describable in sufficient detail that another researcher could, in principle, reproduce them. This includes recording the identity and batch of every research product used.
• Traceability: if an unexpected result occurs, batch records allow a researcher to trace back through the supply chain and identify whether a material-related variable may be relevant.
• Auditability: in regulated or externally reviewed research environments, complete documentation supports compliance with institutional and funding-body requirements.
• Communication: when publishing results or sharing data with collaborators, complete product information allows others to evaluate and build on the work.

Research-Use Terminology

Products in research peptide catalogues are labelled for research use only. This is a regulatory and legal designation indicating that the product has not been evaluated or approved for human therapeutic or diagnostic use by the Therapeutic Goods Administration (TGA) or comparable international regulators. A research-use-only designation does not comment on the quality or purity of the product; it describes the regulatory framework within which the product is supplied.

For a more detailed look at how Australian regulations distinguish research products from therapeutic goods, see our guide to peptide regulation in Australia. If you are comparing suppliers, our research peptide supplier checklist outlines the documentation signals to look for.

Australian Research Resources

For researchers working with peptides in Australia, the following resources provide supporting information on testing, documentation and laboratory calculations:

• Testing & Quality — how research peptide purity and identity are verified.
• Certificate of Analysis Library — available analytical documentation.
• Research Library — educational reference material on research terminology and methods.
• Peptide Concentration Calculator — a laboratory tool for solution concentration calculations.
• Research Glossary — an alphabetical reference of laboratory and product terms.
• Product & Batch Documentation — how to access specifications, COAs and batch records.

References and Further Reading

• Therapeutic Goods Administration (TGA). Regulation of therapeutic goods in Australia. Australian Government Department of Health and Aged Care.
• Snyder, L.R., Kirkland, J.J., & Dolan, J.W. (2010). Introduction to Modern Liquid Chromatography (3rd ed.). Wiley.
• de Hoffmann, E. & Stroobant, V. (2007). Mass Spectrometry: Principles and Applications (3rd ed.). Wiley.
• National Measurement Institute (NMI). Chemical and biological measurement services. Australian Government.
• Bulk Aussie Peptides FAQ — additional information on storage, ordering, and product-related questions.